All results

4 results for tests

• AEVI-007

  The main purpose of the study is to evaluate the safety and tolerability of Camoteskimab in participants with Still's Disease. ### Inclusion Criteria: 1.…

  Ages

  18 Years - 75 Years

  Sexes

  All

• DREAM

  The overriding objective of DREAM is to conduct a prospective longitudinal (36 months) observational clinical study to investigate the incidence, etiology, and…

  Ages

  18 Years - 75 Years

  Sexes

  All

• Takeda TAK-999-3001

  The main aim of this study is to learn if fazirsiran reduces liver scarring (fibrosis) compared to placebo. Other aims are to learn if fazirsiran slows down…

  Ages

  18 Years - 75 Years

  Sexes

  All

• First-In-Human Study of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221

  This study is an international, multi-center, study of Pompe disease patients that are currently receiving enzyme-replacement therapy (ERT). The purpose of…

  Ages

  18 Years - 75 Years

  Sexes

  All